PRKAR1B mutation associated with a new neurodegenerative disorder with unique pathology.
暂无分享,去创建一个
J. Lebbink | A. Smit | W. Kamphorst | J. V. van Swieten | A. Verkerk | R. Willemsen | J. Swieten | A. Rozemuller | M. Neumann | K. Li | H. Seelaar | S. V. van Duinen | L. Severijnen | G. Breedveld | V. Bonifati | G. Lammers | R. Hukema | T. H. Wong | W. Z. Chiu | D. Hondius | P. Frick | E. Bakker | Petra Frick
[1] V. Timmerman,et al. Neurofilament phosphorylation and their proline‐directed kinases in health and disease , 2012, Journal of the peripheral nervous system : JPNS.
[2] Mason R. Mackey,et al. A Small Novel A-Kinase Anchoring Protein (AKAP) That Localizes Specifically Protein Kinase A-Regulatory Subunit I (PKA-RI) to the Plasma Membrane* , 2012, The Journal of Biological Chemistry.
[3] R. Nixon,et al. The C-Terminal Domains of NF-H and NF-M Subunits Maintain Axonal Neurofilament Content by Blocking Turnover of the Stationary Neurofilament Network , 2012, PloS one.
[4] Ping Zhang,et al. Assembly of allosteric macromolecular switches: lessons from PKA , 2012, Nature Reviews Molecular Cell Biology.
[5] Susan S. Taylor,et al. Localization and quaternary structure of the PKA RIβ holoenzyme , 2012, Proceedings of the National Academy of Sciences.
[6] A. Rogers,et al. Molecular Pathways: The Role of NR4A Orphan Nuclear Receptors in Cancer , 2012, Clinical Cancer Research.
[7] J. M. Dale,et al. Neurofilament Phosphorylation during Development and Disease: Which Came First, the Phosphorylation or the Accumulation? , 2012, Journal of amino acids.
[8] N. Cairns,et al. Gigaxonin mutation analysis in patients with NIFID , 2011, Neurobiology of Aging.
[9] L. Annunziato,et al. Control of PKA stability and signalling by the RING ligase praja2 , 2011, Nature Cell Biology.
[10] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[11] H. Hakonarson,et al. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.
[12] Susan S. Taylor,et al. Structure of D-AKAP2:PKA RI complex: insights into AKAP specificity and selectivity. , 2010, Structure.
[13] M. Strong,et al. Post-transcriptional control of neurofilaments: New roles in development, regeneration and neurodegenerative disease , 2010, Trends in Neurosciences.
[14] H. Kretzschmar,et al. Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease , 2009, Acta Neuropathologica.
[15] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[16] I. Bossis,et al. In vitro functional studies of naturally occurring pathogenic PRKAR1A mutations that are not subject to nonsense mRNA decay , 2008, Human mutation.
[17] Maria Martinez-Lage,et al. Clinical and pathological heterogeneity of neuronal intermediate filament inclusion disease. , 2008, Archives of neurology.
[18] J. Morris,et al. TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. , 2007, The American journal of pathology.
[19] Bruce L. Miller,et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.
[20] J. Hardy,et al. Mutation analysis of patients with neuronal intermediate filament inclusion disease (NIFID) , 2006, Neurobiology of Aging.
[21] T. Gotow,et al. Aggregate formation and phosphorylation of neurofilament-L Pro22 Charcot-Marie-Tooth disease mutants. , 2006, Human molecular genetics.
[22] Tom H. Lindner,et al. easyLINKAGE-Plus--automated linkage analyses using large-scale SNP data , 2005, Bioinform..
[23] D. Dickson,et al. Screening for neurofilament inclusion disease using α-internexin immunohistochemistry , 2005, Neurology.
[24] J. Trojanowski,et al. Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease , 2004, Neurology.
[25] J. Trojanowski,et al. alpha-internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease. , 2004, The American journal of pathology.
[26] J. Trojanowski,et al. α-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseases , 2004, Acta Neuropathologica.
[27] C. Angiari,et al. Giant axon and neurofilament accumulation in Charcot–Marie–Tooth disease type 2E , 2004, Neurology.
[28] D. Wotton. Faculty Opinions recommendation of A transforming growth factor beta-induced Smad3/Smad4 complex directly activates protein kinase A. , 2004 .
[29] Robert C. Edgar,et al. MUSCLE: multiple sequence alignment with high accuracy and high throughput. , 2004, Nucleic acids research.
[30] M. Uhler,et al. A Transforming Growth Factor β-Induced Smad3/Smad4 Complex Directly Activates Protein Kinase A , 2004, Molecular and Cellular Biology.
[31] Nick C Fox,et al. Neurofilament inclusion body disease: a new proteinopathy? , 2003, Brain : a journal of neurology.
[32] Veeranna,et al. Phosphorylation of the Head Domain of Neurofilament Protein (NF-M) , 2003, Journal of Biological Chemistry.
[33] J. Warsh,et al. Altered cAMP‐dependent protein kinase subunit immunolabeling in post‐mortem brain from patients with bipolar affective disorder , 2003, Journal of neurochemistry.
[34] K. Taskén,et al. Specificity in the cAMP/PKA signaling pathway. differential expression, regulation, and subcellular localization of subunits of PKA. , 2000, Frontiers in bioscience : a journal and virtual library.
[35] Daniel F. Gudbjartsson,et al. Allegro, a new computer program for multipoint linkage analysis , 2000, Nature genetics.
[36] R. Roos,et al. Numerous and widespread α-synuclein-negative Lewy bodies in an asymptomatic patient , 1999, Acta Neuropathologica.
[37] R. Liem,et al. Overexpression of α-Internexin Causes Abnormal Neurofilamentous Accumulations and Motor Coordination Deficits in Transgenic Mice , 1999, The Journal of Neuroscience.
[38] R. Nixon,et al. Serine‐23 Is a Major Protein Kinase A Phosphorylation Site on the Amino‐Terminal Head Domain of the Middle Molecular Mass Subunit of Neurofilament Proteins , 1999, Journal of neurochemistry.
[39] J R O'Connell,et al. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. , 1998, American journal of human genetics.
[40] M. Stryker,et al. Comparison of Plasticity In Vivo and In Vitro in the Developing Visual Cortex of Normal and Protein Kinase A RIβ-Deficient Mice , 1998, The Journal of Neuroscience.
[41] C. Miller,et al. Neuropathological Abnormalities in Transgenic Mice Harbouring a Phosphorylation Mutant Neurofilament Transgene , 1998, Journal of neurochemistry.
[42] J. Scott,et al. Type II regulatory subunits are not required for the anchoring-dependent modulation of Ca2+ channel activity by cAMP-dependent protein kinase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[43] E R Kandel,et al. Impaired hippocampal plasticity in mice lacking the Cbeta1 catalytic subunit of cAMP-dependent protein kinase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[44] E R Kandel,et al. Hippocampal long-term depression and depotentiation are defective in mice carrying a targeted disruption of the gene encoding the RI beta subunit of cAMP-dependent protein kinase. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[45] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[46] Jean-Pierre Julien,et al. Functions of intermediate filaments in neuronal development and disease. , 2004, Journal of neurobiology.
[47] R. Roos,et al. Numerous and widespread alpha-synuclein-negative Lewy bodies in an asymptomatic patient. , 1999, Acta neuropathologica.